Cell and Tissue Preservation Market Size & Share, By Type (Cell, Tissue), Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, Research & Development), Product (Equipment, Software, Bio-preservation Media), End User (Biobanks, Hospitals), Cell Provider (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 6686| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Cell and Tissue Preservation Market size is predicted to grow from USD 4.68 billion in 2024 to USD 13.17 billion by 2034, reflecting a CAGR of over 10.9% from 2025 through 2034. The industry revenue is forecasted to reach USD 5.14 billion in 2025.

Base Year Value (2024)
USD 4.68 billion
CAGR (2025-2034)
10.9%
Forecast Year Value (2034)
USD 13.17 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Cell and Tissue Preservation Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: One of the major growth drivers in the Cell and Tissue Preservation Market is the increasing demand for organ transplants and regenerative medicine. As the global population ages and chronic diseases become more prevalent, the need for viable cell and tissue preservation methods has surged. This demand is fueled by the growing awareness of the benefits of cell therapy and regenerative medicine, which require the storage of viable cells for transplantation. Innovations in preservation technologies, such as cryopreservation and biobanking, are enhancing the efficacy and reliability of preservation methods, thereby bolstering market growth. Another significant driver is the rising investments in biotechnology and biopharmaceutical research. The burgeoning biotechnology sector is focusing on developing advanced therapies, necessitating efficient cell and tissue preservation techniques to ensure the availability of high-quality biological materials for research and commercial applications. With government and private funding increasing for life sciences research, the demand for preservation solutions that maintain the integrity and viability of biological samples is expected to rise, positively impacting the market. Technological advancements and innovations in preservation techniques also play a pivotal role in propelling market growth. New methodologies, such as advanced cryopreservation systems, controlled-rate freezing, and novel preservation solutions, are improving the ability to preserve sensitive cell structures and functions effectively. These advancements not only enhance the shelf life and viability of preserved cells and tissues but also increase their usability in a variety of applications, expanding the market potential. Industry Restraints: Despite the growth prospects, the Cell and Tissue Preservation Market faces several restraints, with high costs associated with preservation technologies being a primary barrier. Advanced preservation methods and equipment often require significant capital investment and operational costs, which can limit accessibility, especially for smaller institutions and laboratories. This economic constraint may hinder the widespread adoption of these technologies, particularly in developing regions where budget limitations are a significant concern. Another restraint affecting the market is the stringent regulatory framework governing biobanking and cell preservation. Regulatory bodies impose rigorous guidelines and compliance requirements regarding the collection, storage, and use of biological materials, which can complicate and slow down the process of developing and commercializing preservation solutions. The complexity of navigating these regulations can deter investment and innovation within the industry, potentially stifling market growth.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Cell and Tissue Preservation Market
Largest Region
North America
40% Market Share in 2024
North America The Cell and Tissue Preservation Market in North America is primarily driven by the growing demand for organ transplantation and advancements in preservation technologies. The United States holds a significant share due to its robust healthcare infrastructure, a high number of research laboratories, and increased funding for biomanufacturing and regenerative medicine. Canada also contributes to the market growth with its focus on biotechnology and biopharmaceutical sectors, alongside government initiatives to support organ transplant procedures. However, challenges such as the high cost of preservation equipment and the need for stringent regulations can hinder market expansion. Asia Pacific In the Asia Pacific region, the Cell and Tissue Preservation Market is witnessing rapid growth, particularly in China and Japan, due to increasing investments in healthcare and a rising aging population. China is rapidly advancing in medical research and biobanking, making it a significant player in the market. The Japanese market benefits from its technological innovations and high-quality healthcare services, leading to increased demand for preservation solutions. South Korea is also emerging as a key market with its expanding biotechnology sector and initiatives focused on enhancing organ transplantation methods. However, varying regulatory standards across countries may pose challenges. Europe The Cell and Tissue Preservation Market in Europe is characterized by a strong focus on research and clinical applications, particularly in the United Kingdom, Germany, and France. The UK is leading in the market due to its advanced healthcare system, extensive research activities, and funding for regenerative medicine projects. Germany has a strong biopharmaceutical manufacturing sector and is investing in technologies to improve preservation techniques. France showcases a growing interest in stem cell research and biobanking, further driving market growth. Nevertheless, the complexity of regulations and ethical considerations surrounding cell and tissue preservation may impact the market dynamics in the region.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Cell and Tissue Preservation Market By Type The Cell and Tissue Preservation Market is segmented into two primary types: Cell and Tissue. The cell preservation segment is anticipated to dominate the market due to the growing applications in cell therapy and research. The ability to maintain the viability and functionality of cells during storage is crucial for various therapeutic and clinical applications. The tissue preservation segment, while smaller, is also gaining traction, especially in regenerative medicine and transplantation, as advancements in preservation techniques enhance tissue viability over extended periods. Application The application segment of the Cell and Tissue Preservation Market includes Therapeutics, Drug Discovery, Gene Therapy, IVF Treatment, Cell Therapy, and Research & Development. The therapeutics application is projected to hold the largest market share, driven by increasing demand for advanced therapies. Drug discovery and gene therapy are also significant contributors, as pharmaceutical companies focus on utilizing preserved cells for innovative treatments. IVF treatment is another crucial application due to the need for preserving gametes and embryos. The research and development segment is vital for academic and clinical studies, emphasizing the importance of preserved biological materials in advancing medical science. Product In terms of products, the market is categorized into Equipment, Software, and Bio-Preservation Media. Equipment, including freezers, cryopreservation units, and storage devices, is essential for maintaining optimal preservation conditions. The software segment is becoming increasingly important for monitoring and managing storage systems, ensuring compliance with regulatory standards. Bio-preservation media plays a critical role in providing the necessary environment for cell and tissue preservation, thus supporting the growth of this segment as novel preservation solutions emerge. End User The End User segment consists of Biobanks and Hospitals. Biobanks are pivotal in the cell and tissue preservation market, as they serve as repositories for biological samples used in various research applications. The growth of biobanks is driven by rising research initiatives and personalized medicine. Hospitals also represent a significant end user, as they require preserved cells and tissues for clinical procedures, transplantations, and therapeutic applications. The collaboration between hospitals and biobanks supports the advancement of healthcare delivery systems. Cell Provider The Cell Provider segment includes categories like CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, and Others. Among these, Mesenchymal Stem Cells (MSC) and Induced Pluripotent Stem Cells (iPSC) are gaining popularity due to their versatility in research and therapeutic applications. CD34+ and CD19+ cells are critical in hematological treatments, demonstrating significant demand in cell therapies. Tumor cells also represent a vital segment as their preservation is essential for cancer research and drug development. The increasing focus on personalized medicine and regenerative therapies is expected to drive growth within the overall cell provider segment.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape of the Cell and Tissue Preservation Market is characterized by significant advancements in preservation technologies, increasing demand for organ transplants, and a growing emphasis on regenerative medicine. Key players are focusing on innovation and strategic collaborations to enhance their product offerings and service delivery. The market is driven by both pharmaceutical companies and biotechnology firms that aim to improve preservation methods and techniques to increase the viability and functionality of cells and tissues post-preservation. Additionally, regulatory considerations and the need for compliance with healthcare standards are influencing the competitive dynamics, leading to increased investment in research and development. Top Market Players 1. Synthecon, Inc. 2. Biolife Solutions, Inc. 3. Thermo Fisher Scientific, Inc. 4. Vascular Biogenics Ltd. 5. Cryoport, Inc. 6. ReproCELL, Inc. 7. Sigma-Aldrich Corporation 8. Charles River Laboratories International, Inc. 9. Fujifilm Holdings Corporation 10. Lonza Group AG
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Cell and Tissue Preservation Market — Custom Segments

Segment Sub-Segment
No segment data available.

Cell and Tissue Preservation Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →